{
    "Trade/Device Name(s)": [
        "MeMed BV",
        "MeMed BV\u00ae",
        "MeMed BV\u2122",
        "MeMed Key\u00ae"
    ],
    "Submitter Information": "MeMed Diagnostics Ltd.",
    "510(k) Number": "K222332",
    "Predicate Device Reference 510(k) Number(s)": [
        "K210254"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "QPS"
    ],
    "Summary Letter Date": "August 2, 2022",
    "Summary Letter Received Date": "August 2, 2022",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3215"
    ],
    "Regulation Name(s)": [
        "Device To Detect And Measure Non-Microbial Analyte(S) In Human Clinical Specimens To Aid In Assessment Of Patients With Suspected Sepsis"
    ],
    "Analyte Class(es)": [
        "immunology",
        "chemistry"
    ],
    "Analyte(s)": [
        "TRAIL",
        "IP-10",
        "CRP"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [
        "Cartridge"
    ],
    "Instrument(s)/Platform(s)": [
        "MeMed Key\u00ae analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Automated semi-quantitative immunoassay",
        "Chemiluminescence"
    ],
    "Methodologies": [
        "Immunoassay",
        "Chemiluminescence detection"
    ],
    "Submission Type(s)": [
        "Test",
        "Analyzer",
        "Cartridge",
        "Reagent",
        "Control",
        "Component"
    ],
    "Document Summary": "FDA 510(k) summary for MeMed BV immunoassay measuring host proteins TRAIL, IP-10, and CRP to aid differentiation of bacterial versus viral infection in serum",
    "Indications for Use Summary": "Aid to differentiate bacterial from viral infection by measuring host proteins TRAIL, IP-10, and CRP in adult and pediatric serum samples from patients presenting with suspected acute infection (less than seven days of symptoms), used in emergency or urgent care in conjunction with clinical assessment",
    "fda_folder": "Microbiology"
}